Skip to main content
Clinical Trials/NCT06048341
NCT06048341Not yet recruitingNot Applicable

Effects of Sono-guided Femoral Nerve Block in Arthroscopic Surgery for Meniscal Tear Under Spinal Anesthesia: A Randomized Controlled Trial

Chuncheon Sacred Heart Hospital1 site in 1 country100 target enrollmentStarted: September 18, 2023Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
100
Locations
1
Primary Endpoint
postoperative pain after 24hours

Study Overview

Brief Summary

The investigators will compare the results of sono-guided femoral nerve block in arthroscopic surgery for meniscal tear under spinal anesthesia

Detailed Description

This study is a randomized controlled trial of 100 patients, who underwent history taking, physical examinations, x-rays, and MRI or ultrasonography, and were diagnosed with meniscal tear from september 2023 to august 2028. The 100 patients will be assigned to Group I (with femoral nerve block) or Group II (without femoral nerve block) under double-blinded randomization. The randomization will be performed by an independent nurse using a computerized random sequence generator. The operators who participated in the procedure will be blinded to the participant's information. Both group will undergo spinal anesthesia for arthroscopic meniscal surgery. After anesthesia, sono-guided femoral nerve block will be performed. The injection for group1 is 20 mL ropivacaine and for groupII is 20 mL 0.9% saline. A visual analog scale (VAS) for pain will be recorded 1, 3, 6, 12, 18, 24, 36, 48 hours after the operation. VAS scores range from 0 to 10, with 0 being no pain and 10 being the most severe pain ever experienced. Injection with ultrasonography will be performed by a single anesthesiologist. 3 orthopedic surgeons will perform the surgery.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Double (Participant, Investigator)

Eligibility Criteria

Ages
19 Years to 60 Years (Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •who require simultaneous surgery for concomitant cartilage injury, collateral ligament tear.
  • •who have previously undergone surgical treatment within the knee joint.
  • •who have declined to participate in the research.
  • •where medical, surgical, or anesthetic complications occurred during surgery.
  • •other cases deemed necessary by the researchers.

Arms & Interventions

FNB

Experimental

sono-guided femoral nerve injection with 20ml ropivacaine

Intervention: Sono-guided injection (Procedure)

No FNB

Placebo Comparator

sono-guided femoral nerve injection with 20ml 0.9% saline

Intervention: Sono-guided injection (Procedure)

No FNB

Placebo Comparator

sono-guided femoral nerve injection with 20ml 0.9% saline

Intervention: Saline injection (Drug)

FNB

Experimental

sono-guided femoral nerve injection with 20ml ropivacaine

Intervention: Ropivacaine injection (Drug)

Outcomes

Primary Outcomes

postoperative pain after 24hours

Time Frame: 24hours

VAS (Visual analog scale) measured 24 hours after operation * the unabbreviated scale title: The visual analog scale * the minimum and maximum values: 0, 10 * higher scores mean a worse outcome.

Secondary Outcomes

  • postoperative pain after 1, 3, 6, 12, 18, 48 hours(1, 3, 6, 12, 18, 48 hours)

Investigators

Sponsor
Chuncheon Sacred Heart Hospital
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Jung-Taek Hwang

Professor

Chuncheon Sacred Heart Hospital

Study Sites (1)

Loading locations...

Similar Trials